Biopsy performed after the two cycles of treatment and immunohistochemistry analysis revealed that infiltration of CD4+ T lymphocyte, CD8+ T lymphocyte, and CD68+ macrophage in the tumor microenvironment was significantly increased compared with that before treatment (Fig. 3A). The gene discussed is CD8A; the disease is neoplasm.